Co-morbidities and Hyperinflation Are Independent Risk Factors of All-cause Mortality in Very Severe COPD

References

• Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370:765–73.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133:14–20.
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Lareau SC, Meek PM. Predictors of survival in COPD: more than just the FEV1. Respir Med 2008; 102 Suppl 1:S27–35.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187:347–365.
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, Casanova C, Montes Oca M de, Mendez RA, The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005–1012.
   PubMed Web of Science ®Google Scholar
• Puhan MA, Garcia-Aymerich J, Frey M, ter Riet G, Anto JM, Agusti AG, Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009; 374:704–711.
   PubMed Web of Science ®Google Scholar
• Jones RC, Donaldson GC, Chavannes NH, Kida K, Dickson-Spillmann M, Harding S, Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. Am J Respir Crit Care Med 2009; 180:1189–1195.
   PubMed Web of Science ®Google Scholar
• Casanova C, Cote C, Torres JP de, Aguirre-Jaime A, Marin JM, Pinto-Plata V, Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171:591–597.
   PubMed Web of Science ®Google Scholar
• Budweiser S, Jorres RA, Riedl T, Heinemann F, Hitzl AP, Windisch W, Predictors of survival in COPD patients with chronic hypercapnic respiratory failure receiving noninvasive home ventilation. Chest 2007; 131:1650–1658.
   PubMed Web of Science ®Google Scholar
• Corsonello A, Antonelli Incalzi R, Pistelli R, Pedone C, Bustacchini S, Lattanzio F. Co-morbidities of chronic obstructive pulmonary disease. Curr Opin Pulm Med 2011; 17 Suppl 1:S21–28.
   PubMedGoogle Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373–383.
   PubMedGoogle Scholar
• Almagro P, Cabrera FJ, Diez J, Boixeda R, Alonso Ortiz MB, Murio C, Co-morbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest 2012; 142:1126–1133.
   PubMed Web of Science ®Google Scholar
• Marti S, Munoz X, Rios J, Morell F, Ferrer J. Body weight and co-morbidity predict mortality in COPD patients treated with oxygen therapy. Eur Respir J 2006; 27:689–696.
   PubMed Web of Science ®Google Scholar
• Terzano C, Conti V, Di Stefano F, Petroianni A, Ceccarelli D, Graziani E, Co-morbidity, hospitalization, and mortality in COPD: results from a longitudinal study. Lung 2010; 188:321–329.
   PubMed Web of Science ®Google Scholar
• Antonelli Incalzi R, Fuso L, Rosa M de, Forastiere F, Rapiti E, Nardecchia B, Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10:2794–800.
   PubMed Web of Science ®Google Scholar
• Groenewegen KH, Schols AMWJ, Wouters EFM. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124:459–467.
   PubMed Web of Science ®Google Scholar
• Divo M, Cote C, Torres JP de, Casanova C, Marin JM, Pinto-Plata V, Co-morbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186:155–161.
   PubMed Web of Science ®Google Scholar
• Celli BR. Predictors of mortality in COPD. Respir Med 2010; 104:773–779.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32:962–969.
   PubMed Web of Science ®Google Scholar
• Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined co-morbidity index. J Clin Epidemiol 1994; 47:1245–1251.
   PubMed Web of Science ®Google Scholar
• Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988; 93:580–586.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995; 152:1107–1136.
   PubMed Web of Science ®Google Scholar
• Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byrne PM, Anderson SD, Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:53–83.
   PubMedGoogle Scholar
• American Thoracic Society (ATS) statement. Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111–117.
   PubMed Web of Science ®Google Scholar
• Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998; 158:1384–1387.
   PubMed Web of Science ®Google Scholar
• Keaney NP, Ansari K, Munby J, Price M, Kay A, Taylor IK. P219 Ten year mortality in a primary care COPD cohort: multidimensional index BOD more discriminant than GOLD staging. Thorax 2011; 66:A157.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF3, Feldman HI, A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604–612.
   PubMed Web of Science ®Google Scholar
• McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007; 62:411–415.
   PubMed Web of Science ®Google Scholar
• Lange P, Marott JL, Vestbo J, Olsen KR, Ingebrigtsen TS, Dahl M, Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 2012;186:975–81.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Aguayo SM, Petty TL, Redd SC. Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med 2003; 163:1475–1480.
   PubMed Web of Science ®Google Scholar
• Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: Role of co-morbidities. Eur Respir J 2006; 28:1245–1257.
   PubMed Web of Science ®Google Scholar
• Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007; 29:923–929.
   PubMed Web of Science ®Google Scholar
• Kollert F, Tippelt A, Muller C, Jorres RA, Porzelius C, Pfeifer M Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure. Respir Care 2013;58(7):1204–1212.
   PubMed Web of Science ®Google Scholar
• Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Bakke P, Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185:1065–1072.
   PubMed Web of Science ®Google Scholar
• Chailleux E, Laaban J, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest 2003; 123:1460–1466.
   PubMed Web of Science ®Google Scholar
• Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:1856–1861.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Doherty DE, Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006; 100:115–122.
   PubMed Web of Science ®Google Scholar
• Almagro P, Calbo E, Ochoa Echaguen A de, Barreiro B, Quintana S, Heredia JL, Mortality after hospitalization for COPD. Chest 2002; 121:1441–1448.
   PubMed Web of Science ®Google Scholar
• Laurin C, Lavoie KL, Bacon SL, Dupuis G, Lacoste G, Cartier A, Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest 2007; 132:148–155.
   PubMed Web of Science ®Google Scholar
• van Manen JG, Bindels PJE, Dekker FW, IJzermans CJ, van der Zee JS, Schade E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 2002; 57:412–416.
   PubMed Web of Science ®Google Scholar
• Buch P, Friberg J, Scharling H, Lange P, Prescott E. Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J 2003; 21:1012–1016.
   PubMed Web of Science ®Google Scholar
• Ng T, Niti M, Tan W, Cao Z, Ong K, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167:60–67.
   PubMed Web of Science ®Google Scholar
• Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax 2012; 67:970–976.
   PubMed Web of Science ®Google Scholar
• Voogd JN de, Wempe JB, Koeter GH, Postema K, van Sonderen E, Ranchor AV, Depressive symptoms as predictors of mortality in patients with COPD. Chest 2009; 135:619–625.
   PubMed Web of Science ®Google Scholar
• Incalzi RA, Corsonello A, Pedone C, Battaglia S, Paglino G, Bellia V. Chronic renal failure: a neglected co-morbidity of COPD. Chest 2010; 137:831–837.
   PubMed Web of Science ®Google Scholar
• Marin JM, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluna JJ, Multicomponent indices to predict survival in COPD: The COllaborative COhorts to assess multicomponent indices of COPD in Spain-COCOMICS study. Eur Respir J 2013;42(2):323–332.
   PubMed Web of Science ®Google Scholar
• Lahaije AJMC, van Helvoort HAC, Dekhuijzen PNR, Vercoulen JH, Heijdra YF. Resting and ADL-induced dynamic hyperinflation explain physical inactivity in COPD better than FEV1. Respir Med 2013; 107:834–840.
   PubMed Web of Science ®Google Scholar
• Vassaux C, Torre-Bouscoulet L, Zeineldine S, Cortopassi F, Paz-Diaz H, Celli BR, Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J 2008; 32:1275–1282.
   PubMed Web of Science ®Google Scholar
• Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010; 362:217–227.
   PubMed Web of Science ®Google Scholar
• Watz H, Waschki B, Meyer T, Kretschmar G, Kirsten A, Claussen M, Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest 2010; 138:32–38.
   PubMed Web of Science ®Google Scholar
• O'Donnell DE, Laveneziana P. The clinical importance of dynamic lung hyperinflation in COPD. COPD 2006; 3:219–232.
   PubMedGoogle Scholar
• Waschki B, Kirsten A, Holz O, Muller K, Meyer T, Watz H, Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011; 140:331–342.
   PubMed Web of Science ®Google Scholar
• Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348:2059–2073.
   PubMed Web of Science ®Google Scholar
• Smith BM, Kawut SM, Bluemke DA, Basner RC, Gomes AS, Hoffman E, Pulmonary hyperinflation and left ventricular mass: The multi-ethnic study of atherosclerosis COPD study. Circulation 2013; 127:1503–1511.
   PubMed Web of Science ®Google Scholar
• Antonelli-Incalzi R, Corsonello A, Pedone C, Trojano L, Acanfora D, Spada A, Drawing impairment predicts mortality in severe COPD. Chest 2006; 130:1687–1694.
   PubMed Web of Science ®Google Scholar
• Grant I, Heaton RK, McSweeny AJ, Adams KM, Timms RM. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 1982; 142:1470–1476.
   PubMed Web of Science ®Google Scholar